Mapping AML heterogeneity - multi-cohort transcriptomic analysis identifies novel clusters and divergent ex-vivo drug responses
Jeppe F. Severens(Leiden University Medical Center), Erik B. van den Akker(Leiden University Medical Center), Bert A. van der Reijden(Radboud University Nijmegen), Emin Onur Karakaslar(Leiden University Medical Center), Marcel Reinders(Leiden University), Hendrik Veelken(University of Freiburg), Peter van Balen(Meander Medisch Centrum), Elena Sánchez‐López(Leiden University Medical Center), Constantijn J.M. Halkes(Radboud University Nijmegen), Redmar R. van den Berg(Leiden University Medical Center), Marieke Griffioen(Leiden University Medical Center)
Cited by 30
Related Papers
Eleven grand challenges in single-cell data science
|Genome biology|2020|1.5k
Molecular Maps of the Reorganization of Genome-Nuclear Lamina Interactions during Differentiation
|Molecular Cell|2010|1.1k
Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party
|Blood|2018|1k